跳至主要内容
临床试验/JPRN-UMIN000001542
JPRN-UMIN000001542未知未知

An exploratory study for development of hemodynamic indicators for clinical effectiveness of methylphenidate in children with AD/HD - An exploratory study for development of hemodynamic indicators for clinical effectiveness of methylphenidate in children with AD/HD

Shimada Ryoiku Center0 个研究点目标入组 20 人开始时间: 2008年12月2日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6years-old 至 12years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. A patient with severe anxiety or agitation. 2. A patient with glaucoma. 3. A patient with thyroidal dysfunction 4. A patient with arrythmia or abnormal blood pressure. 5. A patient with history of allergic reaction or severe side effects with methylphenidate. 6. A patient with severe mood disorder 7. A patient with motor tics, Tourette's syndrome, or family history of Tourette's syndrome. 8. A patient with pheochromocytoma. 9. A patient who receives medication of MAO inhibitor. 10. A patient with epilepsy. 11. A patient with schizophrenia, psychotic disorders, bipolar disorder. 12. A patient with history of drug abuse or alcohol dependence. 13. A patient with significant mental retardation (FIQ<70, WISC-III).

研究者

发起方
Shimada Ryoiku Center

相似试验